The Health Equity Innovation Series is a monthly talk series hosted at Stanford Biodesign that brings together a community of researchers, physicians, thought leaders, and entrepreneurs to educate, inspire, and engage communities around equitable health innovation.
The 2026 Annual Symposium on Risks and Opportunities of AI in Pharmaceutical Medicine is jointly sponsored by the American Statistical Association, Amgen, Genentech, Northeastern University, Novo Nordisk, Pfizer, and the University of California at Berkeley. The symposium will take place October 13–14 at the University of California at Berkeley. This forum is expected to serve as a platform for distinguished statisticians, data scientists, regulators, and other professionals to address the challenges and opportunities of AI in pharmaceutical medicine; to foster collaboration among industry, academia, regulatory agencies, and professional associations; and to propose recommendations with policy implications for proper implementation of AI in promoting public health.
The Stanford Center for Digital Health Annual Symposium brings researchers, clinicians, and business leaders together on the Stanford campus to discuss defining opportunities of our time. The brightest minds in technology, academia, policy and medicine will participate in this all-day event. The event aims to inspire thoughtful conversations and action at the intersection of technology and health.